Y mAbs Therapeutics (YMAB) — Tangible Net Worth Ratio

Latest as of June 2025: 97.5%

Y mAbs Therapeutics (YMAB) has a Tangible Net Worth Ratio of 97.5% as of June 2025. This metric is calculated by deducting intangible assets ($2.18 Million) from net assets ($87.49 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of Y mAbs Therapeutics to track the company's year-over-year net asset growth rate.

Tangible NW Ratio

97.5%
Tangible equity / total equity

Net Assets (Equity)

$87.49 Million
USD

Intangible Assets

$2.18 Million
Goodwill, patents, brand value

Total Assets

$117.21 Million
USD

Y mAbs Therapeutics Tangible Net Worth Ratio (2016–2024)

This chart shows how Y mAbs Therapeutics's Tangible Net Worth Ratio has changed across 9 annual periods from 2016 to 2024. As of June 2025, the ratio stands at 97.5%, reflecting net assets of $87.49 Million with intangible assets of $2.18 Million USD. For live market cap and overall valuation, see market value of Y mAbs Therapeutics.

Annual Tangible Net Worth Ratio for Y mAbs Therapeutics (2016–2024)

The table below presents the year-by-year Tangible Net Worth Ratio for Y mAbs Therapeutics from 2016 to 2024, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See YMAB FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Tangible NW Ratio Net Assets (USD) Intangible Assets Total Assets Change (pp)
2024 97.5% $92.00 Million $2.28 Million $119.90 Million ▲ +0.1 pp
2023 97.4% $100.98 Million $2.63 Million $127.87 Million ▲ +0.1 pp
2022 97.3% $109.22 Million $2.99 Million $141.46 Million ▼ -1.8 pp
2021 99.1% $180.11 Million $1.66 Million $212.78 Million ▼ -0.9 pp
2020 100.0% $105.84 Million $0.00 $132.05 Million ▲ +0.0 pp
2019 100.0% $198.90 Million $0.00 $216.37 Million ▲ +0.0 pp
2018 100.0% $140.53 Million $0.00 $151.92 Million ▲ +0.0 pp
2017 100.0% $82.15 Million $0.00 $92.13 Million ▲ +0.0 pp
2016 100.0% $12.06 Million $0.00 $17.26 Million
pp = percentage points